M2 macrophages-based immunotherapy: A new therapeutic approach in liver fibrosis
Open Access
- 2 June 2025
- journal article
- review article
- Published by Maad Rayan Publishing Company in Advanced Pharmaceutical Bulletin
- Vol. 15 (2) , 314-325
Abstract
Liver fibrosis (LF) is a pathological condition resulting from a chronic inflammatory response to multiple etiological factors, including viral infections, excessive alcohol consumption, and metabolic disorders. The important role of macrophages in this process, especially the M2 subtype, has attracted attention as a potential target for macrophage-based immunotherapy. M2 macrophages have anti-inflammatory and reparative properties that enable them to modulate the immune response and facilitate repairing damaged tissues. They participate in reducing fibrogenic features in term of gene expression and histological markers associated with LF. These cells phagocytose apoptotic cells and matrix components. M2 macrophage-based immunotherapy has shown great potential in ameliorating LF through mechanisms involving the IL-10/STAT3 and TGF-β/SMAD signaling pathways, which are essential in suppressing the pro-inflammatory response and supporting tissue regeneration. However, significant challenges such as individual resistance to therapy and the potential for promoting fibrosis suggest that further development and research are needed to optimize the safety and efficacy of this therapy in clinical applications. This study provides comprehensive insights into the role of M2 macrophages in LF and explores their potential as an innovative therapeutic approach in treating LF.Keywords
This publication has 102 references indexed in Scilit:
- Interferon regulatory factor 3 plays an anti-inflammatory role in microglia by activating the PI3K/Akt pathwayJournal of Neuroinflammation, 2011
- Alternative Activation of Macrophages: Mechanism and FunctionsImmunity, 2010
- Arginase-1–Expressing Macrophages Suppress Th2 Cytokine–Driven Inflammation and FibrosisPLOS Pathogens, 2009
- Functional role and species-specific contribution of arginases in pulmonary fibrosisAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Macrophages Sequentially Change Their Functional Phenotype in Response to Changes in Microenvironmental InfluencesThe Journal of Immunology, 2005
- The chemokine system in diverse forms of macrophage activation and polarizationTrends in Immunology, 2004
- Influence of Alternatively and Classically Activated Macrophages on Fibrogenic Activities of Human FibroblastsCellular Immunology, 2000
- M-1/M-2 Macrophages and the Th1/Th2 ParadigmThe Journal of Immunology, 2000
- Alternative versus Classical Activation of MacrophagesPathobiology, 1999
- Gene Regulation in Macrophage Activation: Differential Regulation of Genes Encoding for Tumor Necrosis Factor, Interleukin-1, JE, and KC by interferon-γ and LipopolysaccharideJournal of Leukocyte Biology, 1990